ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026
A three-dimensional finite element-based biomechanical properties analysis of the 10th thoracic vertebra invaded by bone metastases for clinical procedure optimization.
Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThoracic vertebral metastases can compromise spinal stability. Percutaneous vertebroplasty (PVP) and pedicle screw fixation (PSF) are commonly used reconstruction strategies, but comparative biomechanical evidence across different metastatic invasion patterns remains limited.
methodsA CT-based T9-T11 finite element model was reconstructed from a healthy adult volunteer. Four T10 metastatic invasion patterns with increasing vertebral body and posterior element involvement were simulated, and untreated, PVP, PSF, and combined PVP + PSF reconstruction models were generated. The primary analyses used a geometrically linear static formulation under a standardized 1200 N axial compressive load combined with a 7.5 Nm flexion moment. T10 displacement and nodal-averaged maximum von Mises stress were evaluated.
resultsProgressive metastatic invasion increased T10 displacement and stress, with extensive bilateral vertebral body and posterior element involvement producing the largest mechanical response. Compared with untreated metastatic models, PVP, PSF, and combined PVP + PSF reduced displacement and/or stress to different extents. PVP showed substantial stress reduction across the simulated groups, whereas PSF primarily improved mechanical stability by limiting displacement, particularly in more extensive invasion patterns. Combined PVP + PSF produced the lowest overall mechanical response in most models, but this finding was interpreted as a biomechanical trend rather than evidence of clinical superiority.
conclusionUnder a standardized geometrically linear loading condition, finite element simulations showed invasion-dependent mechanical deterioration and treatment-specific stabilization trends in a deterministic T9-T11 model. These findings provide exploratory biomechanical evidence for understanding thoracic metastatic instability and reconstruction strategies, but the extreme untreated Group 4 response is an instability indicator rather than a finite-deformation clinical prediction and requires cautious interpretation and further patient-specific validation.
Indexed as
Identifiers
42811136What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.